Natural Product (NP) Details
| General Information of the NP (ID: NP0822) | |||||
|---|---|---|---|---|---|
| Name |
Cinnamaldehyde
|
||||
| Synonyms |
cinnamic aldehyde
Click to Show/Hide
|
||||
| Species Origin | Muhlenbergia tenuissima ... | Click to Show/Hide | |||
| Muhlenbergia tenuissima | |||||
| Disease | Fusarium sambucinum infection [ICD-11: 1F2Z] | Investigative | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| ADMET Property |
Absporption
Caco-2 Permeability
-4.767
MDCK Permeability
-4.639
PAMPA
- -
HIA
- - -
Distribution
VDss
-0.415
PPB
94.9%
BBB
+
Metabolism
CYP1A2 inhibitor
+++
CYP1A2 substrate
- - -
CYP2C19 inhibitor
+++
CYP2C19 substrate
- - -
CYP2C9 inhibitor
+++
CYP2C9 substrate
++
CYP2D6 inhibitor
- -
CYP2D6 substrate
+++
CYP3A4 inhibitor
- - -
CYP3A4 substrate
- - -
CYP2B6 inhibitor
+++
CYP2B6 substrate
- - -
CYP2C8 inhibitor
+++
HLM Stability
- - -
Excretion
CLplasma
11.086
T1/2
1.395
Toxicity
DILI
- -
Rat Oral Acute Toxicity
-
FDAMDD
-
Respiratory
-
Human Hepatotoxicity
+
Ototoxicity
- -
Drug-induced Nephrotoxicity
-
Drug-induced Neurotoxicity
++
Hematotoxicity
- - -
Genotoxicity
-
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C9H8O
|
||||
| PubChem CID | |||||
| Canonical SMILES |
C1=CC=C(C=C1)C=CC=O
|
||||
| InChI |
1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+
|
||||
| InChIKey |
KJPRLNWUNMBNBZ-QPJJXVBHSA-N
|
||||
| CAS Number |
CAS 104-55-2
|
||||
| Herb ID | |||||
| ETMC ID | |||||
| SymMap ID | |||||
| TCMSP ID | |||||
| TTD Drug ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| Doxorubicin | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
| Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | U-87MG ATCC | CVCL_0022 | Glioblastoma | Homo sapiens | ||
| Experimental
Result(s) |
Cinnamaldehyde is able to enhance the apoptosis induced by DOX on human glioblastoma cells. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Transformation-sensitive p120 (TRPA1) | Molecule Info | [3] | |
| Transient receptor cation channel V3 (TRPV3) | Molecule Info | [4] | ||
| KEGG Pathway | Inflammatory mediator regulation of TRP channels | Click to Show/Hide | ||
| Reactome | TRP channels | Click to Show/Hide | ||